The Global Cardiac Implants Market is expected to register a CAGR of 7.82% and is anticipated to reach USD 38,054.3 million by 2023. Cardiac implants are devices implanted in the heart which monitor and maintain the normal functions of the heart. Cardiac implants monitor the condition of the heart, detect fluctuations, and provide this information to the doctor or the health care provider. Additionally, they are used in the treatment of heart diseases such as myocardial ischemia, arrhythmias, and acute myocardial infarction, among others., The factors boosting the growth of the global cardiac implants market include the growing prevalence of cardiac diseases and the growing population of older adults across the globe. Despite the drivers, the high cost associated with cardiac implants and risk of injections due to these implants may restrain the market growth over the forecast period., , Synopsis/Market Dynamics, , The growth of the global cardiac implants market is driven by factors such as growing geriatric population coupled with the increasing prevalence of cardiac diseases. Generally, the older population is more susceptible to diseases as with aging, the heart and blood vessels become stiff which can lead to conditions such as heart failure, coronary artery disease, and atrial fibrillation, among others. According to the data published by the Centers for Disease Control and Prevention (CDC) in 2017, about 2.7 to 6.1 million people in the US had atrial fibrillation, a common form of heart arrhythmia. However, the high cost of cardiac implants are a risk of injections is likely to affect the growth of the market., Global Cardiac Implants Market Revenue, by End User, 2017 (USD Mn) , , Segmentation, , The global cardiac implants market has been segmented into cardiac rhythm management devices, coronary stents, prosthetic heart valve devices, ventricular assist devices, implantable loop recorder/implantable cardiac monitor, and others. By indication, the market has been segmented into arrhythmias, myocardial ischemia, acute myocardial infarction, heart failure, and others. On the basis of end-user, the market has been segmented into hospitals, cardiac care centers, ambulatory centers & home care, aca

The Global Cardiac Implants Market i s expected to register a CAGR of 7.82% and is anticipated to reach USD 38,054.3 million by 2023. Cardiac implants are devices implanted in the heart which monitor and maintain the normal functions of the heart. Cardiac implants monitor the condition of the heart, detect fluctuations, and provide this information to the doctor or the health care provider. Additionally, they are used in the treatment of heart diseases such as myocardial ischemia, arrhythmias, and acute myocardial infarction, among others.

The factors boosting the growth of the global cardiac implants market include the growing prevalence of cardiac diseases and the growing population of older adults across the globe. Despite the drivers, the high cost associated with cardiac implants and risk of injections due to these implants may restrain the market growth over the forecast period.



Synopsis/Market Dynamics



The growth of the global cardiac implants market is driven by factors such as growing geriatric population coupled with the increasing prevalence of cardiac diseases. Generally, the older population is more susceptible to diseases as with aging, the heart and blood vessels become stiff which can lead to conditions such as heart failure, coronary artery disease, and atrial fibrillation, among others. According to the data published by the Centers for Disease Control and Prevention (CDC) in 2017, about 2.7 to 6.1 million people in the US had atrial fibrillation, a common form of heart arrhythmia. However, the high cost of cardiac implants are a risk of injections is likely to affect the growth of the market.

Global Cardiac Implants



Market Revenue, by End User, 2017 (USD Mn)

Segmentation

The global cardiac implants market has been segmented into cardiac rhythm management devices, coronary stents, prosthetic heart valve devices, ventricular assist devices, implantable loop recorder/implantable cardiac monitor, and others. By indication, the market has been segmented into arrhythmias, myocardial ischemia, acute myocardial infarction, heart failure, and others. On the basis of end-user, the market has been segmented into hospitals, cardiac care centers, ambulatory centers & home care, academic institutes, and others. The hospitals segment accounted for a market value of USD 8,721.6 million in 2017.

Global Cardiac Implants Market Share, by Region, 2017 (%)

Regional Analysis

The global cardiac implants market, based on region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is segmented into North America and South America. North America is expected to hold the largest market share owing to the rising prevalence of cardiac diseases and high adoption rates of cardiac implantable electronic devices. The cardiac implants market in Europe is anticipated to grow owing to the factors such as rising funding from the government for the healthcare sector and growing initiatives for heart patients by insurance companies in the region.



Moreover, the growing prevalence of several heart diseases in the region has led to an increase in adoption of cardiac implants. In Europe, Italy accounted for a market share of 9.9% in the year 2017. The Asia-Pacific region is anticipated to be the fastest growing market for cardiac implants. Factors such as increasing geriatric population, changing lifestyle, and increasing medical tourism in the Asia-Pacific region are expected to drive the market. The Middle East and Africa accounts for the least share of the global market owing to the presence of poor and slow developing countries, especially, in the African region.

Key Players

The prominent players in the global cardiac implants market are Abbott (US), Amg International (Germany), Edwards Lifesciences Corporation (US), B. Braun Melsungen AG (Germany), Biotronik (US), Boston Scientific Corporation (US), LivaNova PLC (UK), Medtronic Plc (US), SynCardia Systems, Inc. (Arizona), and Terumo Corporation (Japan)

Some of the key strategies followed by the players operating in the global cardiac implants market were innovation, product development, acquisition, and expansion.



In July 2018, Terumo Corporation acquired the China-based Essen Technology to enter the drug-eluting stent market in China.



In February 2018, Medtronic launched the first 2.0 mm Drug-Eluting stent Resolute Onyx in the US. The new product is intended to help interventional cardiologists treat patients with coronary artery disease (CAD) who have small vessels.



In October 2015, Boston Scientific Corporation received the FDA approval for SYNERGY Bioabsorbable Polymer Drug-Eluting Stent System for the treatment of coronary artery disease. With this approval, the company gained the rights to market the products in the US



Market Segmentation

Global Cardiac Implants Market, by Device



Cardiac Rhythm Management Devices



Coronary Stents



Prosthetic Heart Valve Devices



Ventricular Assist Devices



Implantable Loop recorder/ Implantable Cardiac Monitor



Others



Global Cardiac Implants Market, by Indication



Arrhythmias



Myocardial Ischemia



Acute Myocardial Infarction



Heart Failure



Others



Global Cardiac Implants Market, by End User



Hospitals



Cardiac Care Centers



Ambulatory Centers & Home Care



Academic Institutes



Others



Global Cardiac Implants Market, by Region



Americas



North America



US

Canada











Latin America



Europe



Western Europe

Germany

UK

France

Italy

Spain

Rest of Western Europe







Eastern Europe



Asia-Pacific



China

Japan

India

Australia

South Korea

Rest of Asia-Pacific











Middle East & Africa



Middle East

Africa









Available Additional Customizations



Company Profiles of Other Key Players



Thoratec Corporation



LEPU MEDICAL



Carmat SA



Bard Incorporated



Abiomed



Cardiobridge Gmbh



Asahi Kasei Corporation (Evaheart Medical U.S.A., Inc.)



CardiacAssist Technologies



Berlin Heart GmbH



Angiotech Pharmaceuticals



Supply & Demand Analysis



Intended Audience



Medical Device Manufacturers and Distributors



Government Research Organizations



Hospitals and Clinics



Regulatory Agencies



Frequently Asked Questions (FAQ) :